Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 20639 | 451 | 29.1 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
| 143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
| 230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
| 20639 | 1 | ZONISAMIDE//NEUROSCI MOL BIOL//CAS 68291 97 4 | 451 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ZONISAMIDE | authKW | 8649306 | 48% | 59% | 218 |
| 2 | NEUROSCI MOL BIOL | address | 341334 | 2% | 46% | 11 |
| 3 | CAS 68291 97 4 | authKW | 135410 | 0% | 100% | 2 |
| 4 | CLONIC CL SEIZURE | authKW | 135410 | 0% | 100% | 2 |
| 5 | COUNCIL ON DENTAL THERAPEUTICS | authKW | 135410 | 0% | 100% | 2 |
| 6 | SEAL OF ACCEPTANCE | authKW | 135410 | 0% | 100% | 2 |
| 7 | TONIC EXTENSOR TE SEIZURE | authKW | 135410 | 0% | 100% | 2 |
| 8 | EL MOUSE | authKW | 134282 | 2% | 18% | 11 |
| 9 | CA2 INDUCED CA2 RELEASING SYSTEM | authKW | 90272 | 0% | 67% | 2 |
| 10 | CHILDRENS HOSP ANNA MEYER | address | 90272 | 0% | 67% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Clinical Neurology | 3753 | 40% | 0% | 180 |
| 2 | Pharmacology & Pharmacy | 1256 | 32% | 0% | 144 |
| 3 | Neurosciences | 737 | 25% | 0% | 113 |
| 4 | Psychiatry | 480 | 13% | 0% | 57 |
| 5 | Chemistry, Medicinal | 88 | 5% | 0% | 22 |
| 6 | Behavioral Sciences | 52 | 3% | 0% | 13 |
| 7 | Medical Laboratory Technology | 27 | 2% | 0% | 7 |
| 8 | Dentistry, Oral Surgery & Medicine | 25 | 2% | 0% | 11 |
| 9 | Pediatrics | 24 | 4% | 0% | 16 |
| 10 | Toxicology | 13 | 2% | 0% | 11 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | NEUROSCI MOL BIOL | 341334 | 2% | 46% | 11 |
| 2 | CHILDRENS HOSP ANNA MEYER | 90272 | 0% | 67% | 2 |
| 3 | BIOMED SCI DENT SCI MORPHOFUNCT IMAGING | 67705 | 0% | 100% | 1 |
| 4 | BIOPOLAR OUTPATIENT PROGRAM | 67705 | 0% | 100% | 1 |
| 5 | CHILD NEUROL POEDIAT SLEEP | 67705 | 0% | 100% | 1 |
| 6 | CHILDRENS PAVIL CHILD NEUROL | 67705 | 0% | 100% | 1 |
| 7 | CLIN NEUROSCIOBES EATING DISORDERS T | 67705 | 0% | 100% | 1 |
| 8 | CLIN NEUROSCIPSYCHOPHARMACOL PROGRAM | 67705 | 0% | 100% | 1 |
| 9 | CLIN TRIAL ANTIEPILEPT DRUGS | 67705 | 0% | 100% | 1 |
| 10 | CRICMINSERMCNRS | 67705 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EPILEPSY RESEARCH | 21417 | 8% | 1% | 35 |
| 2 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 12281 | 5% | 1% | 21 |
| 3 | JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY | 11532 | 3% | 1% | 13 |
| 4 | EPILEPSIA | 4726 | 6% | 0% | 25 |
| 5 | IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE | 2477 | 1% | 1% | 4 |
| 6 | JOURNAL OF PUBLIC HEALTH DENTISTRY | 1921 | 1% | 0% | 6 |
| 7 | CLINICAL NEUROPHARMACOLOGY | 1798 | 2% | 0% | 8 |
| 8 | JOURNAL OF PHARMACOLOGICAL SCIENCES | 1414 | 2% | 0% | 7 |
| 9 | EPILEPSY & BEHAVIOR | 1331 | 2% | 0% | 9 |
| 10 | EPILEPTIC DISORDERS | 1068 | 1% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BRODIE, MJ , BEN-MENACHEM, E , CHOUETTE, I , GIORGI, L , (2012) ZONISAMIDE: ITS PHARMACOLOGY, EFFICACY AND SAFETY IN CLINICAL TRIALS.ACTA NEUROLOGICA SCANDINAVICA. VOL. 126. ISSUE . P. 19-28 | 41 | 87% | 14 |
| 2 | FAROOQ, MU , MOORE, PW , BHATT, A , ABURASHED, R , KASSAB, MY , (2008) THERAPEUTIC ROLE OF ZONISAMIDE IN NEUROPSYCHIATRIC DISORDERS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 10. P. 968-975 | 58 | 69% | 10 |
| 3 | HOLDER, JL , WILFONG, AA , (2011) ZONISAMIDE IN THE TREATMENT OF EPILEPSY.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 12. ISSUE 16. P. 2573 -2581 | 41 | 82% | 16 |
| 4 | SERRANO-CASTRO, PJ , VILLANUEVA, V , (2013) ZONISAMIDE IN THE EPILEPSY TREATMENT: A LITERATURE REVIEW FROM ADD-ON THERAPY TO MONOTHERAPY.REVISTA DE NEUROLOGIA. VOL. 56. ISSUE 8. P. 429 -438 | 36 | 88% | 1 |
| 5 | COX, JH , SERI, S , CAVANNA, AE , (2014) ZONISAMIDE AS A TREATMENT FOR PARTIAL EPILEPTIC SEIZURES: A SYSTEMATIC REVIEW.ADVANCES IN THERAPY. VOL. 31. ISSUE 3. P. 276 -288 | 38 | 78% | 2 |
| 6 | KOTHARE, SV , KALEYIAS, J , (2008) ZONISAMIDE: REVIEW OF PHARMACOLOGY, CLINICAL EFFICACY, TOLERABILITY, AND SAFETY.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 4. ISSUE 4. P. 493-506 | 49 | 65% | 28 |
| 7 | VERROTTI, A , LOIACONO, G , DI SABATINO, F , ZACCARA, G , (2013) THE ADVERSE EVENT PROFILE OF ZONISAMIDE: A META-ANALYSIS.ACTA NEUROLOGICA SCANDINAVICA. VOL. 128. ISSUE 5. P. 297-304 | 31 | 86% | 8 |
| 8 | SCHULZE-BONHAGE, A , (2015) THE SAFETY AND LONG-TERM EFFICACY OF ZONISAMIDE AS ADJUNCTIVE THERAPY FOR FOCAL EPILEPSY.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 15. ISSUE 8. P. 857 -865 | 30 | 83% | 0 |
| 9 | TAN, HJ , MARTLAND, TR , APPLETON, RE , KNEEN, R , (2010) EFFECTIVENESS AND TOLERABILITY OF ZONISAMIDE IN CHILDREN WITH EPILEPSY: A RETROSPECTIVE REVIEW.SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. VOL. 19. ISSUE 1. P. 31-35 | 27 | 93% | 11 |
| 10 | SCHULZE-BONHAGE, A , (2010) ZONISAMIDE IN THE TREATMENT OF EPILEPSY.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 11. ISSUE 1. P. 115-126 | 38 | 64% | 14 |
Classes with closest relation at Level 1 |